Movement Disorders
Movement Disorders is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 238. It has a price of 2500 €. It has an SJR impact factor of 2,988 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,988.
Movement Disorders focuses its scope in these topics and keywords: parkinsons, disease, study, stimulation, patients, parkinsonian, trial, early, clinical, randomized, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
2,988
H-index
238
Docs (year)
337
Docs 3y
1169
Total refs
11454
Cites 3y
6168
Citable 3y
768
Cites/Doc 2y
5.1
Ref/Doc
33.99
Immediate OA
2500 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Botulinum toxin in neuro-urological disorders
View moreWide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation
View moreClinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation
View moreClinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration
View moreClinical characteristics of Parkinson's disease among Inuit in Greenland and inhabitants of the Faroe Islands and Als (Denmark)
View moreClinical and genetic features of myoclonus-dystonia in 3 cases: A video presentation
View moreChorea-acanthocytosis associated with tourettism
View moreChorea and contraceptives: Case report with pet study and review of the literature
View moreCerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy
View moreCerebrospinal fluid Abeta42levels in multiple system atrophy
View moreCardiovascular effects of methamphetamine in Parkinson's disease patients
View moreCabergoline versus levodopa monotherapy
View moreBotulinum toxin treatment of secretory disorders
View more"Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus (""Limp Man Syndrome"")"
View moreBasic and therapeutic aspects of neurotonins
View moreAutosomal recessive juvenile parkinsonismCys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis
View moreAsymmetrical awake bruxism associated with multiple system atrophy
View moreAssessing quality of life in Parkinson's disease: Can a short-form questionnaire be useful?
View moreAssessing comorbidity in patients with Parkinson's disease
View moreAnxiety in musicians with focal dystonia and those with chronic pain
View moreAnomalies of asymmetry of clinical signs in parkinsonism
View moreAlteration in a-synuclein mRNA expression in Parkinson's disease
View moreAdverse effects of dopamine potentiation by long-term treatment with selegiline
View moreAccuracy of clinical diagnosis of progressive supranuclear palsy
View more